Citations

Mayo Clinic

Clear

215 citation(s) found for "Xu, Vivian".

2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care (Endorsed by the American heart assocation, the cardiological society of India, and sociedad latino American
Rihal, Charanjit S. , Naidu, Srihari S. , Givertz, Michael M. , Szeto, Wilson Y. , Burke, James A. , Kapur, Navin K. , Garratt, Kirk N. , Goldstein, James A. , Dimas, V. Vivian , Tu, Thomas, Rihal, Charanjit S. , Kern, Morton J.

Catheterization and Cardiovascular Interventions | April 7, 2015 | Volume: 85 | Issue: 7 | Pages: No page available

10.1002/ccd.25720 | PMID 25851050 Get It

Although historically the intra‐aortic balloon pump has been the only mechanical circulatory support device available to clinicians, a number of new devices have become commercially available and have entered clinical practice. These include axial flow pumps, such as Impella®; left atrial to femoral artery bypass pumps, specifically the TandemHeart; and new devices for institution of extracorporeal membrane oxygenation. These devices differ significantly in their hemodynamic effects, insertion, monitoring, and clinical applicability. This document reviews the physiologic impact on the circulation of these devices and their use in specific clinical situations. These situations include patients undergoing high‐risk percutaneous coronary intervention, those presenting with cardiogenic shock, and acute decompensated heart failure. Specialized uses for right‐sided support and in pediatric populations are discussed and the clinical utility of mechanical circulatory support devices is reviewed, as are the American College of Cardiology/American Heart Association clinical practice guidelines. © 2015 by The Society for Cardiovascular Angiography and Interventions, The American College of Cardiology Foundation, The Heart Failure Society of America, and The Society for Thoracic Surgery.
Vitamin D Attenuates Cytokine‐Induced Remodeling in Human Fetal Airway Smooth Muscle Cells
Britt, Rodney D. , Faksh, Arij , Vogel, Elizabeth R. , Chu, Vivian H. , Pandya, Hitesh , Amrani, Yassine , Martin, Richard J. , Prakash, Y. S. , Thompson, Michael A. , Pabelick, Christina M. , Prakash, Y S , Vogel, Elizabeth R

Journal of Cellular Physiology | September 9, 2014 | Volume: 230 | Issue: 6 | Pages: 1189-1198

10.1002/jcp.24814 | PMID 25204635 Get It

Asthma in the pediatric population remains a significant contributor to morbidity and increasing healthcare costs. Vitamin D3 insufficiency and deficiency have been associated with development of asthma. Recent studies in models of adult airway diseases suggest that the bioactive Vitamin D3 metabolite, calcitriol (1,25‐dihydroxyvitamin D3; 1,25(OH)2D3), modulates responses to inflammation; however, this concept has not been explored in developing airways in the context of pediatric asthma. We used human fetal airway smooth muscle (ASM) cells as a model of the early postnatal airway to explore how calcitriol modulates remodeling induced by pro‐inflammatory cytokines. Cells were pre‐treated with calcitriol and then exposed to TNFα or TGFβ for up to 72 h. Matrix metalloproteinase (MMP) activity, production of extracellular matrix (ECM), and cell proliferation were assessed. Calcitriol attenuated TNFα enhancement of MMP‐9 expression and activity. Additionally, calcitriol attenuated TNFα and TGFβ‐induced collagen III expression and deposition, and separately, inhibited proliferation of fetal ASM cells induced by either inflammatory mediator. Analysis of signaling pathways suggested that calcitriol effects in fetal ASM involve ERK signaling, but not other major inflammatory pathways. Overall, our data demonstrate that calcitriol can blunt multiple effects of TNFα and TGFβ in developing airway, and point to a potentially novel approach to alleviating structural changes in inflammatory airway diseases of childhood. J. Cell. Physiol. 230: 1189–1198, 2015. © 2014 Wiley Periodicals, Inc., A Wiley Company
African American Women's Perceptions and Attitudes Regarding Participation in Medical Research: The Mayo Clinic/The Links, Incorporated Partnership
Brewer, LaPrincess C. , Hayes, Sharonne N. , Parker, Monica W. , Balls‐Berry, Joyce E. , Halyard, Michele Y. , Pinn, Vivian W. , Breitkopf, Carmen Radecki , Balls-Berry, Joyce Joy E , Hayes, Sharonne N , Brewer, LaPrincess C

Journal of Women's Health | July 21, 2014 | Volume: 23 | Issue: 8 | Pages: 681-687

10.1089/jwh.2014.4751 | PMID 25046058 Get It

Objective: To examine perceptions and attitudes toward health-related research participation among professional African American women. Methods: Participants were members of an African American women's service organization, The Links, Incorporated. Data were collected via self-administered questionnaires at The Links, Incorporated 2012 National Assembly. Sociodemographics, prior research experience, intention to participate (ITP), willingness to participate (WTP) in a variety of research studies and attitudes about research participation were measured. Results: A total of 381 surveys were analyzed. A majority of respondents were married (66%), employed (69%), and college educated (96%). Median age was 59; 38% reported prior research participation. Overall, 78% agreed with the statement, “Participation in research will mean better care,” 24% agreed “Participation in research is risky” and 3% agreed “Scientists cannot be trusted.” Fifty-two percent agreed with the statement, “Research conducted in the U.S. is ethical.” Mean ITP in research was 4.9±1.7 on a rating scale of 1 (“definitely no”) to 7 (“definitely yes”). WTP was highest for an interview study and providing a blood sample, and lowest for clinical trial and medical record review. Conclusion: Attitudes toward research participation were generally favorable among professional African American women; many expressed WTP in a variety of research study types.
A selected group of large common fragile site genes have decreased expression in oropharyngeal squamous cell carcinomas
Kasperbauer, Jan L. , Tombers, Nicole M. , Wang, Vivian , Mayer, Kevin , Smith, David I., Gao, Ge , Smith, David I.

Genes, Chromosomes and Cancer | January 31, 2014 | Volume: 53 | Issue: 5 | Pages: 392-401

10.1002/gcc.22150 | PMID 24481768 Get It

The common fragile sites (CFSs) are large regions of profound genomic instability found in all individuals. The frequent deletions and other alterations in these regions in multiple cancers has led to the discovery of a number of extremely large genes contained within these regions and several of the large CFS genes have already been demonstrated to function as tumor suppressors involved in the formation of many different cancers. To study the large CFS genes in oropharyngeal squamous cell carcinoma (OPSCC), we did RNA seq analysis from 11 head and neck cancer patients. This revealed that there are six large CFS genes which consistently had decreased expression in the tumor samples compared to their matched normal tissues. These six genes are PARK2, DLG2, NBEA, CTNNA3, DMD, and FHIT. PARK2 and FHIT are located within the two most frequently expressed CFSs and both have been demonstrated to function as tumor suppressors, while the other large genes are found to have frequent alterations in multiple cancers. Validation experiments using real time PCR indicated that over 60% of OPSCC tumors showed decreased expression for all six genes. Both HPV‐positive and HPV‐negative OPSCCs had similar proportions with loss of expression of these genes. Our results suggest that this selected group of large genes might serve as potential tumor suppressors involved in the development of OPSCCs. Further studies are needed to investigate whether the decreased expression observed is due to genomic instability within the CFS regions or the selection for alterations of specific large CFS genes. © 2014 Wiley Periodicals, Inc.
Measurement of renal tissue oxygenation with blood oxygen level-dependent MRI and oxygen transit modeling
Zhang, Jeff L. , Morrell, Glen , Rusinek, Henry , Warner, Lizette, Vivier, P.-H. , Cheung, Alfred K. , Lerman, Lilach O. , Lee, Vivian S. , Rusinek, Henry

American Journal of Physiology-Renal Physiology | January 23, 2014 | Volume: 306 | Issue: 6 | Pages: F579-F587

10.1152/ajprenal.00575.2013 | PMID 24452640 Get It

Blood oxygen level-dependent (BOLD) MRI data of kidney, while indicative of tissue oxygenation level (Po2), is in fact influenced by multiple confounding factors, such as R2, perfusion, oxygen permeability, and hematocrit. We aim to explore the feasibility of extracting tissue Po2 from renal BOLD data. A method of two steps was proposed: first, a Monte Carlo simulation to estimate blood oxygen saturation (SHb) from BOLD signals, and second, an oxygen transit model to convert SHb to tissue Po2. The proposed method was calibrated and validated with 20 pigs (12 before and after furosemide injection) in which BOLD-derived tissue Po2 was compared with microprobe-measured values. The method was then applied to nine healthy human subjects (age: 25.7 ± 3.0 yr) in whom BOLD was performed before and after furosemide. For the 12 pigs before furosemide injection, the proposed model estimated renal tissue Po2 with errors of 2.3 ± 5.2 mmHg (5.8 ± 13.4%) in cortex and −0.1 ± 4.5 mmHg (1.7 ± 18.1%) in medulla, compared with microprobe measurements. After injection of furosemide, the estimation errors were 6.9 ± 3.9 mmHg (14.2 ± 8.4%) for cortex and 2.6 ± 4.0 mmHg (7.7 ± 11.5%) for medulla. In the human subjects, BOLD-derived medullary Po2 increased from 16.0 ± 4.9 mmHg (SHb: 31 ± 11%) at baseline to 26.2 ± 3.1 mmHg (SHb: 53 ± 6%) at 5 min after furosemide injection, while cortical Po2 did not change significantly at ∼58 mmHg (SHb: 92 ± 1%). Our proposed method, validated with a porcine model, appears promising for estimating tissue Po2 from renal BOLD MRI data in human subjects.
Large normal alleles and SCA2 prevalence: lessons from a nationwide study and analysis of the literature
Laffita‐Mesa, José Miguel , Almaguer-Mederos, Luis E. , Kourí, Vivian, Bauer, Peter , Vázquez‐Mojena, Yaimeé , Mariño, Tania Cruz , Velázquez‐Pérez, Luis

Clinical Genetics | July 19, 2013 | Volume: 86 | Issue: 1 | Pages: 96-98

10.1111/cge.12221 | PMID 23865735 Get It

Pazopanib Enhances Paclitaxel-Induced Mitotic Catastrophe in Anaplastic Thyroid Cancer
Isham, Crescent R., Bossou, Ayoko R., Negron, Vivian , Fisher, Kelly E., Marlow, Laura A. , Lingle, Wilma L., Smallridge, Robert C., Sherman, Eric J. , Copland, John A. , Bible, Keith C. , Kumar, Rakesh , Suman, Vera J. , Marlow, Laura

Science Translational Medicine | January 2, 2013 | Volume: 5 | Issue: 166 | Pages: No page available

10.1126/scitranslmed.3004358 | PMID 23283368 Get It

Pazopanib and paclitaxel produce cytotoxic synergy in thyroid cancer models through inhibition of aurora kinase A.
Abstract 3100: Identifying novel chromosomal fusions out of RNAseq data from oropharyngeal cancers
Wang, Vivian W., Laborde, Rebecca R., Asmann, Yan W. , Li, Yang , Eckloff, Bruce W., Tombers, Nicole M. , Olsen, Steven M., Moore, Eric J. , Olsen, Kerry D., Smith, David I., Ma, Jian , Smith, David I.

Cancer Research | August 13, 2012 | Volume: 72 | Issue: 8_Supplement | Pages: 3100-3100

10.1158/1538-7445.am2012-3100 Get It

Abstract Chromosome rearrangements that result in gene fusions have important roles in the initial steps of tumorigenesis especially in leukemias and lymphomas, but the biological and clinical impact of gene fusions in the common solid tumor has been less appreciated. We previously generated RNAseq data from 12 oropharyngeal tumors along with matched normal tissue from the same patients. We utilized and compared two bioinformatic pipelines, SnowShoes-FTD and FusionHunter to identify two novel fusion events involving of MGST3-ZMAT5 and MS4A7-DKFZp586P0123. These fusions were validated utilizing. Reverse transcriptase polymerase chain reaction (RT-PCR) and Sanger sequencing validated. In the first translocation the 5′ UTR of MGST3 was fused with exon 1 of ZMAT5, and in the second translocation the exon 2 of MS4A7 was fused with 3′ UTR of DKFZp586P0123. These precise fusions were not present in the matched normal tissue, however, they were only found in the single tumor in which they were identified. Given a growing and powerful set of high-throughput massively parallel sequencing technologies, the future for genome-wide analysis of chromosome rearrangement appears open in many directions. Ultimately, we hope that this integrative methodology will elucidate key aspects of tumor biology as well as generate novel targets for cancer diagnostics and therapy. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 3100. doi:1538-7445.AM2012-3100
Abstract 5047: Dysregulated microRNAs in cervical neoplasm
Wong, Yick Fu, Cheung, Tak Hong , Man, M.K.N., Yu, Mei, Yim, So Fan, Siu, Nelson S.S., Lo, Keith W.K., Doran, Graeme, Wong, Raymond R.Y., Wang, Vivian W., Smith, David I., Smith, David I., Worley, Michael J. , Chung, Tony K.H.

Cancer Research | August 9, 2012 | Volume: 72 | Issue: 8_Supplement | Pages: 5047-5047

10.1158/1538-7445.am2012-5047 Get It

Abstract MicroRNAs (miRNAs) play an important role in a variety of physiological processes as well as pathophysiological processes, including cancinogenesis. This study was to identify a distinct miRNA expression signature for cervical intraepithelial neoplasia (CIN) and to reveal individual miRNAs that may be involved in the development of cervical carcinoma. Expression profiling using quantitative real-time RT-PCR of 202 miRNAs was performed on micro-dissected high-grade CIN (CIN 2/3) tissues as compared to normal cervical epithelium. The expression of 12 miRNAs including miR-518a, miR-34b, miR-34c, miR-20b, miR-338, miR-9, miR-512-5p, miR-424, miR-345, miR-10a, miR-193b and miR-203 were significantly different between high-grade CIN and normal epithelium. This miRNA signature was further validated by an independent set of high-grade CIN tissue. The same characteristic signature can also be used to distinguish cervical squamous cell carcinoma (SCC) from normal controls. Target prediction analysis revealed that these dysregulated miRNAs control the apoptosis signaling pathway and cell cycle regulation. These findings contribute to understanding of the pathogenesis of cervical carcinoma at the molecular level. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 5047. doi:1538-7445.AM2012-5047